Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pre-Operative Gleason Score and PSA and Clinical Stage in Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer

NCT00769223 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00769223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00769223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pre-Operative Gleason Score and PSA and Clinical Stage in Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer
Lead sponsor
University of California, San Francisco
Phase
Observational
Overall status
Active, not recruiting
Start date
February 25, 1993
Completion date
January 31, 2042
Enrollment
3,561 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer, radiation toxicity